Study Details
A survey about hot flashes in women going through the menopause
This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).
Clinicaltrials.gov ID
The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
Astellas Study ID
The unique identification code given by the study sponsor.
2693-MA-3235
EudraCT ID
The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).
N/A
Condition
Menopause, Hot Flashes
Phase
N/A
Age
40 Years - 65 Years
Sex
Female
Product
fezolinetant
Type
A type of clinical study in which participants are identified as belonging to study groups and are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to a specific interventions/treatment.
Observational
Trial Dates
Nov 2021 - Jan 2022
Masking
Not Available
Enrollment number
2176
Prospective Survey of Women with Vasomotor Symptoms Associated with Menopause in Nordic Europe, Canada, Brazil and Mexico - WARM Study
Study summary
Study documents
Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A survey about hot flashes in women going through the menopause? Contact us by filling our your information to the right and we’ll respond to you.
Locations
IQVIA
London, United Kingdom, N1 8JY